Background illustration for clinical trials search

Paid Clinical Trials Edmond

Discover 575 paid clinical trials in Edmond, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab

for
Atopic Dermatitis
Location: Oklahoma City OK, Birmingham AL, New Albany IN,
Sponsor: ASLAN Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05694884

Phase2, Recruiting

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

for
Acne
Location: Oklahoma City OK, Prosper TX, Carrollton TX, Katy TX,
Sponsor: Sanofi Pasteur, a Sanofi Company

Sex: All

Age: 18 - 45

Code: NCT06316297

Phase1, Phase2, Recruiting

Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

for
Glaucoma
Location: Oklahoma City OK, El Paso TX, Grand Junction CO
Sponsor: Glaukos Corporation

Sex: All

Age: 18+

Code: NCT07075718

Phase2, Recruiting

Clinical Validation and Safety of the AC 12L ECG System Against a Standard of Care 12-Lead ECG (AC 12L ECG)

for
Arrhythmia
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 18+

Code: NCT05617001

Recruiting

PEN-866 in Patients With Advanced Solid Malignancies

for
Carcinoma, Endometrial Adenocarcinoma, Neoplasms,
Location: Oklahoma City OK, Springdale AR, Omaha NE,
Sponsor: Tarveda Therapeutics

Sex: All

Age: 18+

Code: NCT03221400

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

for
Ovarian Cancer, Endometrial Cancer, Germ Cell Tumor,
Location: Oklahoma City OK, Nashville TN, Indianapolis IN,
Sponsor: Xencor, Inc.

Sex: All

Age: 15+

Code: NCT06276491

Phase1, Recruiting

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma

for
Sarcoma
Location: Oklahoma City OK, Dallas TX, Fort Worth TX, Amarillo TX,
Sponsor: University of Leicester

Sex: All

Age: 0 - 49

Code: NCT00020566

Phase3, Recruiting

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

for
Clear Cell Renal Cell Carcinoma
Location: Oklahoma City OK, Nashville TN, Rochester MN,
Sponsor: Xencor, Inc.

Sex: All

Age: 18+

Code: NCT05433142

Phase1, Recruiting

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

for
Arrhythmia, Bradycardia, Heart Failure, Sinus Tachycardia
Location: Oklahoma City OK, Plano TX, Fort Worth TX, Dallas TX,
Sponsor: Medtronic

Sex: All

Age: 0+

Code: NCT00271180

Recruiting

Alleviant ALLAY-HF Study

for
Heart Failure
Location: Oklahoma City OK, Dallas TX, Plano TX, Abilene TX,
Sponsor: Alleviant Medical, Inc.

Sex: All

Age: 40+

Code: NCT05685303

Recruiting

Development of a Breath Analyzer for Asthma Screening

for
Asthma
Location: Norman OK
Sponsor: Ekips Technologies

Sex: All

Age: 4 - 65

Code: NCT00386737

Recruiting

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis
Location: Norman OK, Southlake TX, Dallas TX, Mesquite NV,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184996

Phase3, Recruiting

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Norman OK, Southlake TX, Dallas TX, Mesquite TX,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184931

Phase3, Recruiting

Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC

for
Neurogenic Detrusor Overactivity
Location: Oklahoma City OK, Wichita KS, Little Rock AR, Aurora CO,
Sponsor: Urovant Sciences GmbH

Sex: All

Age: 2 - 17

Code: NCT05491525

Phase2, Phase3, Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

for
Chronic Obstructive Pulmonary Disease
Location: Chickasha OK, Allen TX, Carrollton TX, Dallas TX,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07190209

Phase3, Recruiting